Literature DB >> 1113066

Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin.

E Ruoslahti, A Vaheri.   

Abstract

A cell-type specific glycoprotein antigen (SFA) from fibroblast surface appears in human plasma and serum. The amount of SFA in serum was reduced if the blood coagulation clot was removed at a low temperature. SFA could be bound to Sepharose-conjugated fibrinogen and to fibrin powder at 0 degrees C and was subsequently released when the temperature was elevated to plus 37 degrees C. This procedure resulted in a 10-fold enrichment of SFA relative to other serum proteins. SFA was found to be concentrated in the cryoprecipitate fraction of human plasma and was copurified with the cold insoluble globulin (CIG) with procedures published for the purification of the latter component. SFA/CIG is not soluble at low temperatures as such and its appearance in the cryoprecipitate fraction of plasma is likely to be due to its affinity to cryofibrinogen evident from these experiments. The biological significance of the interaction of fibroblast surface SFA moleculres with fibrin(ogen) is not known.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1113066      PMCID: PMC2190538          DOI: 10.1084/jem.141.2.497

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Alteration of cell-surface proteins by viral transformation and by proteolysis.

Authors:  R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

3.  Changes in a surface-labelled galactoprotein and in glycolipid concentrations in cells transformed by a temperature-sensitive polyoma virus mutant.

Authors:  C G Gahmberg; D Kiehn; S Hakomori
Journal:  Nature       Date:  1974-03-29       Impact factor: 49.962

4.  Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus.

Authors:  A Vaheri; E Ruoslahti
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

5.  The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components.

Authors:  M W Mosesson; R A Umfleet
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

6.  Novel human serum protein from fibroblast plasma membrane.

Authors:  E Ruoslahti; A Vaheri
Journal:  Nature       Date:  1974-04-26       Impact factor: 49.962

7.  Chemical coupling of proteins to agarose.

Authors:  J Porath; R Axen; S Ernback
Journal:  Nature       Date:  1967-09-30       Impact factor: 49.962

8.  Distribution of fibroblast surface antigen: association with fibrillar structures of normal cells and loss upon viral transformation.

Authors:  J Wartiovaara; E Linder; E Ruoslahti; A Vaheri
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

9.  Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration.

Authors:  L Ossowski; J P Quigley; G M Kellerman; E Reich
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

10.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses.

Authors:  L Ossowski; J C Unkeless; A Tobia; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

View more
  72 in total

1.  Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.

Authors:  A A Rostagno; J E Schwarzbauer; L I Gold
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  Effect of fibronectin on the Crithidia luciliae test for anti-double-stranded DNA antibodies.

Authors:  K E Herbert; E Jeffery; D L Scott
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

3.  Changes in cellular glycoproteins after transformation: identification of specific glycoproteins and antigens in sodium dodecyl sulfate gels.

Authors:  K Burridge
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

4.  Products of cultured neuroglial cells: II. The production of fibronectin by C6 glioma cells.

Authors:  J R Baldwin; P E McKeever; T R Booker
Journal:  Neurochem Res       Date:  1985-05       Impact factor: 3.996

5.  Fibronectin of the chorioretinal interface in the monkey: immunohistochemical and immunoelectron microscopic studies.

Authors:  T Ishibashi; T Kohno; N Sorgente; R Patterson; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

6.  Surface glycoproteins of resting and activated human T lymphocytes.

Authors:  L C Andersson; C G Gahmberg
Journal:  Mol Cell Biochem       Date:  1979-10-15       Impact factor: 3.396

7.  Plasma fibronectin in normal subjects and in various disease states.

Authors:  N E Stathakis; A Fountas; E Tsianos
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

8.  Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions.

Authors:  M Vuento; A Vaheri
Journal:  Biochem J       Date:  1979-11-01       Impact factor: 3.857

9.  Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen.

Authors:  H K Kleinman; G R Martin; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

10.  Immunological studies of human placentae: identification and distribution of proteins in immature chorionic villi.

Authors:  P M Johnson; W P Faulk
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.